{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:06:04Z","timestamp":1790553964772,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000970","name":"Stem Cells Australia","doi-asserted-by":"publisher","award":["NRR2017"],"award-info":[{"award-number":["NRR2017"]}],"id":[{"id":"10.13039\/501100000970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite advancements in human pluripotent stem cells (hPSCs) differentiation protocols to generate appropriate neuronal progenitors suitable for transplantation in Parkinson\u2019s disease, resultant grafts contain low proportions of dopamine neurons. Added to this is the tumorigenic risk associated with the potential presence of incompletely patterned, proliferative cells within grafts. Here, we utilised a hPSC line carrying a FailSafe<jats:sup>TM<\/jats:sup> suicide gene (thymidine kinase linked to cyclinD1) to selectively ablate proliferative cells in order to improve safety and purity of neural transplantation in a Parkinsonian model. The engineered FailSafe<jats:sup>TM<\/jats:sup> hPSCs demonstrated robust ventral midbrain specification in vitro, capable of forming neural grafts upon transplantation. Activation of the suicide gene within weeks after transplantation, by ganciclovir administration, resulted in significantly smaller grafts without affecting the total yield of dopamine neurons, their capacity to innervate the host brain or reverse motor deficits at six months in a rat Parkinsonian model. Within ganciclovir-treated grafts, other neuronal, glial and non-neural populations (including proliferative cells), were significantly reduced\u2014cell types that may pose adverse or unknown influences on graft and host function. These findings demonstrate the capacity of a suicide gene-based system to improve both the standardisation and safety of hPSC-derived grafts in a rat model of Parkinsonism.<\/jats:p>","DOI":"10.1038\/s41467-021-23125-9","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T10:12:23Z","timestamp":1622110343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Human stem cells harboring a suicide gene improve the\u00a0safety and standardisation of neural transplants in Parkinsonian rats"],"prefix":"10.1038","volume":"12","author":[{"given":"Isabelle R.","family":"de Luzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6652-0445","authenticated-orcid":false,"given":"Kevin C. L.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron P. J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Durnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan H.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4311-0413","authenticated-orcid":false,"given":"Andras","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-9884","authenticated-orcid":false,"given":"Clare L.","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"23125_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.5966\/sctm.2016-0073","volume":"6","author":"JC Niclis","year":"2017","unstructured":"Niclis, J. C. et al. Efficiently specified ventral midbrain dopamine neurons from human pluripotent stem cells under xeno-free conditions restore motor deficits in Parkinsonian rodents. Stem Cells Transl. Med. 6, 937\u2013948 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"23125_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","volume":"1","author":"A Kirkeby","year":"2012","unstructured":"Kirkeby, A. et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 1, 703\u2013714 (2012).","journal-title":"Cell Rep."},{"key":"23125_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 480, 547\u2013551 (2011).","journal-title":"Nature"},{"key":"23125_CR4","doi-asserted-by":"crossref","unstructured":"Gantner, C. W., Cota-Coronado, A., Thompson, L. H. & Parish, C. L. An optimized protocol for the generation of midbrain dopamine neurons under defined conditions. STAR Protoc.\u00a01,\u00a0100065 (2020).","DOI":"10.1016\/j.xpro.2020.100065"},{"key":"23125_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.stem.2016.09.004","volume":"20","author":"A Kirkeby","year":"2017","unstructured":"Kirkeby, A. et al. Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson\u2019s disease. Cell Stem Cell 20, 135\u2013148 (2017).","journal-title":"Cell Stem Cell"},{"key":"23125_CR6","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.stemcr.2017.08.002","volume":"9","author":"JC Niclis","year":"2017","unstructured":"Niclis, J. C. et al. A PITX3-EGFP reporter line reveals connectivity of dopamine and non-dopamine neuronal subtypes in grafts generated from human embryonic stem cells. Stem Cell Rep. 9, 868\u2013882 (2017).","journal-title":"Stem Cell Rep."},{"key":"23125_CR7","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1523\/JNEUROSCI.1160-19.2019","volume":"39","author":"IR de Luzy","year":"2019","unstructured":"de Luzy, I. R. et al. Isolation of LMX1a ventral midbrain progenitors improves the safety and predictability of human pluripotent stem cell-derived neural transplants in Parkinsonian disease. J. Neurosci. 39, 9521\u20139531 (2019).","journal-title":"J. Neurosci."},{"key":"23125_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13097","volume":"7","author":"B Samata","year":"2016","unstructured":"Samata, B. et al. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1. Nat. Commun. 7, 13097 (2016).","journal-title":"Nat. Commun."},{"key":"23125_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stem.2020.01.010","volume":"26","author":"CW Gantner","year":"2020","unstructured":"Gantner, C. W. et al. Viral delivery of GDNF promotes functional integration of human stem cell grafts in Parkinson\u2019s disase. Cell Stem Cell 26, 1\u201315 (2020).","journal-title":"Cell Stem Cell"},{"key":"23125_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.5966\/sctm.2014-0011","volume":"3","author":"JC Aguila","year":"2014","unstructured":"Aguila, J. C. et al. Selection based on FOXA2 expression is not sufficient to enrich for dopamine neurons from human pluripotent stem cells. Stem Cells Transl. Med. 3, 1032\u20131042 (2014).","journal-title":"Stem Cells Transl. Med."},{"key":"23125_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi, D. et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep. 2, 337\u2013350 (2014).","journal-title":"Stem Cell Rep."},{"key":"23125_CR12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.stemcr.2017.08.016","volume":"9","author":"D Lehnen","year":"2017","unstructured":"Lehnen, D. et al. IAP-based cell sorting results in homogeneous transplantable dopaminergic precursor cells derived from human pluripotent stem cells. Stem Cell Rep. 9, 1207\u20131220 (2017).","journal-title":"Stem Cell Rep."},{"key":"23125_CR13","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","volume":"365","author":"A Di Stasi","year":"2011","unstructured":"Di Stasi, A. et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N. Engl. J. Med. 365, 1673\u20131683 (2011).","journal-title":"N. Engl. J. Med."},{"key":"23125_CR14","doi-asserted-by":"publisher","first-page":"e81131","DOI":"10.1371\/journal.pone.0081131","volume":"8","author":"W Ou","year":"2013","unstructured":"Ou, W., Li, P. & Reiser, J. Targeting of herpes simplex virus 1 thymidine kinase gene sequences into the OCT4 locus of human induced pluripotent stem cells. PLoS ONE 8, e81131 (2013).","journal-title":"PLoS ONE"},{"key":"23125_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/scd.2007.0235","volume":"17","author":"A Hara","year":"2008","unstructured":"Hara, A. et al. Neuron-like differentiation and selective ablation of undifferentiated embryonic stem cells containing suicide gene with Oct-4 promoter. Stem Cells Dev. 17, 619\u2013627 (2008).","journal-title":"Stem Cells Dev."},{"key":"23125_CR16","doi-asserted-by":"publisher","first-page":"32338","DOI":"10.1074\/jbc.M112.383810","volume":"287","author":"Z Rong","year":"2012","unstructured":"Rong, Z., Fu, X., Wang, M. & Xu, Y. A scalable approach to prevent teratoma formation of human embryonic stem cells. J. Biol. Chem. 287, 32338\u201332345 (2012).","journal-title":"J. Biol. Chem."},{"key":"23125_CR17","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/mtm.2016.69","volume":"6","author":"V Tieng","year":"2016","unstructured":"Tieng, V. et al. Elimination of proliferating cells from CNS grafts using a Ki67 promoter-driven thymidine kinase. Mol. Ther. Methods Clin. Dev. 6, 16069 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"23125_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-018-0733-7","volume":"563","author":"Q Liang","year":"2018","unstructured":"Liang, Q. et al. Linking a cell-division gene and a suicide gene to define and improve cell therapy safety. Nature 563, 701\u2013704 (2018).","journal-title":"Nature"},{"key":"23125_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/mt.2011.273","volume":"20","author":"RA Morgan","year":"2012","unstructured":"Morgan, R. A. Live and let die: a new suicide gene therapy moves to the clinic. Mol. Ther. 20, 11\u201313 (2012).","journal-title":"Mol. Ther."},{"key":"23125_CR20","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","volume":"276","author":"C Bonini","year":"1997","unstructured":"Bonini, C. et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719\u20131724 (1997).","journal-title":"Science"},{"key":"23125_CR21","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1038\/mtna.2015.57","volume":"5","author":"AG Kotini","year":"2016","unstructured":"Kotini, A. G., de Stanchina, E., Themeli, M., Sadelain, M. & Papapetrou, E. P. Escape mutations, ganciclovir resistance, and teratoma formation in human iPSCs expressing an HSVtk suicide gene. Mol. Ther. Nucleic Acids 5, e284 (2016).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"23125_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1155","volume":"2","author":"Y Arai","year":"2011","unstructured":"Arai, Y. et al. Neural stem and progenitor cells shorten S-phase on commitment to neuron production. Nat. Commun. 2, 154 (2011).","journal-title":"Nat. Commun."},{"key":"23125_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF01190834","volume":"18","author":"RS Nowakowski","year":"1989","unstructured":"Nowakowski, R. S., Lewin, S. B. & Miller, M. W. Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J. Neurocytol. 18, 311\u2013318 (1989).","journal-title":"J. Neurocytol."},{"key":"23125_CR24","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.neuroscience.2007.03.037","volume":"146","author":"EM Torres","year":"2007","unstructured":"Torres, E. M., Monville, C., Gates, M. A., Bagga, V. & Dunnett, S. B. Improved survival of young donor age dopamine grafts in a rat model of Parkinson\u2019s disease. Neuroscience 146, 1606\u20131617 (2007).","journal-title":"Neuroscience"},{"key":"23125_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2012.04.002","volume":"236","author":"CR Bye","year":"2012","unstructured":"Bye, C. R., Thompson, L. H. & Parish, C. L. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into Parkinsonian mice. Exp. Neurol. 236, 58\u201368 (2012).","journal-title":"Exp. Neurol."},{"key":"23125_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/096368979500400118","volume":"4","author":"TB Freeman","year":"1995","unstructured":"Freeman, T. B. et al. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 4, 141\u2013154 (1995).","journal-title":"Cell Transplant."},{"key":"23125_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.antiviral.2016.05.019","volume":"132","author":"I Boujemla","year":"2016","unstructured":"Boujemla, I. et al. Pharmacokinetics and tissue diffusion of ganciclovir in mice and rats. Antivir. Res. 132, 111\u2013115 (2016).","journal-title":"Antivir. Res."},{"key":"23125_CR28","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1460-9568.1990.tb00400.x","volume":"2","author":"RJ Mandel","year":"1990","unstructured":"Mandel, R. J., Brundin, P. & Bjorklund, A. The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur. J. Neurosci. 2, 888\u2013894 (1990).","journal-title":"Eur. J. Neurosci."},{"key":"23125_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","volume":"12","author":"RA Barker","year":"2013","unstructured":"Barker, R. A., Barrett, J., Mason, S. L. & Bjorklund, A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson\u2019s disease. Lancet Neurol. 12, 84\u201391 (2013).","journal-title":"Lancet Neurol."},{"key":"23125_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.stemcr.2019.10.001","volume":"13","author":"CR Bye","year":"2019","unstructured":"Bye, C. R. et al. Transcriptional profiling of xenogeneic transplants: examining human pluripotent stem cell-derived grafts in the rodent brain. Stem Cell Rep. 13, 877\u2013890 (2019).","journal-title":"Stem Cell Rep."},{"key":"23125_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16225-5","volume":"11","author":"K Tiklova","year":"2020","unstructured":"Tiklova, K. et al. Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson\u2019s disease. Nat. Commun. 11, 2434 (2020).","journal-title":"Nat. Commun."},{"key":"23125_CR32","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.1523\/JNEUROSCI.2079-07.2007","volume":"27","author":"T Carlsson","year":"2007","unstructured":"Carlsson, T., Carta, M., Winkler, C., Bjorklund, A. & Kirik, D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson\u2019s disease. J. Neurosci. 27, 8011\u20138022 (2007).","journal-title":"J. Neurosci."},{"key":"23125_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nn863","volume":"5","author":"P Hagell","year":"2002","unstructured":"Hagell, P. et al. Dyskinesias following neural transplantation in Parkinson\u2019s disease. Nat. Neurosci. 5, 627\u2013628 (2002).","journal-title":"Nat. Neurosci."},{"key":"23125_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","volume":"20","author":"AG Kotini","year":"2017","unstructured":"Kotini, A. G. et al. Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia. Cell Stem Cell 20, 315\u2013328.e317 (2017).","journal-title":"Cell Stem Cell"},{"key":"23125_CR35","first-page":"1024","volume":"42","author":"LF Lopez-Cortes","year":"2001","unstructured":"Lopez-Cortes, L. F. et al. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Investigative Ophthalmol. Vis. Sci. 42, 1024\u20131028 (2001).","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"23125_CR36","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","volume":"11","author":"RA Barker","year":"2015","unstructured":"Barker, R. A., Drouin-Ouellet, J. & Parmar, M. Cell-based therapies for Parkinson disease-past insights and future potential. Nat. Rev. Neurol. 11, 492\u2013503 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"23125_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.pbr.2016.11.011","volume":"230","author":"A Kirkeby","year":"2017","unstructured":"Kirkeby, A., Parmar, M. & Barker, R. A. Strategies for bringing stem cell-derived dopamine neurons to the clinic: a European approach (STEM-PD). Prog. Brain Res. 230, 165\u2013190 (2017).","journal-title":"Prog. Brain Res."},{"key":"23125_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/bs.pbr.2017.02.008","volume":"230","author":"L Studer","year":"2017","unstructured":"Studer, L. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial. Prog. Brain Res. 230, 191\u2013212 (2017).","journal-title":"Prog. Brain Res."},{"key":"23125_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/cne.23801","volume":"524","author":"M Turrero Garcia","year":"2016","unstructured":"Turrero Garcia, M., Chang, Y., Arai, Y. & Huttner, W. B. S-phase duration is the main target of cell cycle regulation in neural progenitors of developing ferret neocortex. J. Comp. Neurol. 524, 456\u2013470 (2016).","journal-title":"J. Comp. Neurol."},{"key":"23125_CR40","unstructured":"Cavalieri, B. Geometric degl: indivisible (Unione Tipografico, Editrice., Turin, (1966)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23125-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23125-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23125-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T12:30:44Z","timestamp":1669984244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23125-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23125"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23125-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"4 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.N. is an inventor on the patent application covering the safe-cell technology (PCT\/CA2016\/050256). A.N. is a co-founder and shareholder of panCELLa Inc, having exclusive license to the technology. The other authors (I.D.L., K.C.L.L., C.J.P.H., J.D., N.M., L.H.T., C.L.P.) declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3275"}}